Stonepine Capital Management »

Enanta Pharmaceuticals shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 305k 11.97
2025-06-30 $4.6M 604k 7.56
2025-03-31 $3.3M 591k 5.52
2024-12-31 $1.9M 332k 5.75
2022-03-31 $8.5M 120k 71.18
2019-09-30 $7.8M 130k 60.08
2019-06-30 $5.5M 66k 84.39
2019-03-31 $5.8M 61k 95.51
2017-12-31 $13M 218k 58.68
2017-09-30 $18M 390k 46.80
2017-06-30 $18M 492k 35.98
2017-03-31 $5.7M 185k 30.80
2016-12-31 $7.8M 232k 33.50
2015-12-31 $2.3M 71k 33.02